396 related articles for article (PubMed ID: 9730885)
1. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
Satterthwaite AB; Lowell CA; Khan WN; Sideras P; Alt FW; Witte ON
J Exp Med; 1998 Sep; 188(5):833-44. PubMed ID: 9730885
[TBL] [Abstract][Full Text] [Related]
2. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
[TBL] [Abstract][Full Text] [Related]
3. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
[TBL] [Abstract][Full Text] [Related]
4. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
Middendorp S; Dingjan GM; Maas A; Dahlenborg K; Hendriks RW
J Immunol; 2003 Dec; 171(11):5988-96. PubMed ID: 14634110
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.
Takeshita H; Taniuchi I; Kato J; Watanabe T
Int Immunol; 1998 Apr; 10(4):435-44. PubMed ID: 9620599
[TBL] [Abstract][Full Text] [Related]
7. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
Khan WN
Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380
[TBL] [Abstract][Full Text] [Related]
8. A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency.
Verhagen AM; Wallace ME; Goradia A; Jones SA; Croom HA; Metcalf D; Collinge JE; Maxwell MJ; Hibbs ML; Alexander WS; Hilton DJ; Kile BT; Starr R
J Immunol; 2009 Feb; 182(4):2020-9. PubMed ID: 19201855
[TBL] [Abstract][Full Text] [Related]
9. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.
Craxton A; Jiang A; Kurosaki T; Clark EA
J Biol Chem; 1999 Oct; 274(43):30644-50. PubMed ID: 10521450
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
Mizuno T; Rothstein TL
J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
[TBL] [Abstract][Full Text] [Related]
12. A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase.
Satterthwaite AB; Willis F; Kanchanastit P; Fruman D; Cantley LC; Helgason CD; Humphries RK; Lowell CA; Simon M; Leitges M; Tarakhovsky A; Tedder TF; Lesche R; Wu H; Witte ON
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6687-92. PubMed ID: 10829070
[TBL] [Abstract][Full Text] [Related]
13. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1.
Schubart DB; Rolink A; Schubart K; Matthias P
J Immunol; 2000 Jan; 164(1):18-22. PubMed ID: 10604987
[TBL] [Abstract][Full Text] [Related]
15. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
Middendorp S; Hendriks RW
J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.
Wahl MI; Fluckiger AC; Kato RM; Park H; Witte ON; Rawlings DJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11526-33. PubMed ID: 9326643
[TBL] [Abstract][Full Text] [Related]
17. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40.
Khan WN; Nilsson A; Mizoguchi E; Castigli E; Forsell J; Bhan AK; Geha R; Sideras P; Alt FW
Int Immunol; 1997 Mar; 9(3):395-405. PubMed ID: 9088978
[TBL] [Abstract][Full Text] [Related]
18. Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking.
Oda A; Ikeda Y; Ochs HD; Druker BJ; Ozaki K; Handa M; Ariga T; Sakiyama Y; Witte ON; Wahl MI
Blood; 2000 Mar; 95(5):1663-70. PubMed ID: 10688822
[TBL] [Abstract][Full Text] [Related]
19. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
20. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.
Wu HJ; Venkataraman C; Estus S; Dong C; Davis RJ; Flavell RA; Bondada S
J Immunol; 2001 Aug; 167(3):1263-73. PubMed ID: 11466342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]